Authors:
BLACK SB
SHINEFIELD HR
BERGEN R
HART C
KREMERS R
LAVETTER A
LEMESURIER J
MOROZUMI PA
RAY P
LEWIS EM
FIREMAN B
SCHWALBE J
HALLAM P
SHANDLING M
DEKKER C
GRANOFF DM
IZU A
PODDA A
Citation: Sb. Black et al., SAFETY AND IMMUNOGENICITY OF CHIRON BIOCINE(R) RECOMBINANT ACELLULAR PERTUSSIS-DIPHTHERIA-TETANUS VACCINE IN INFANTS AND TODDLERS/, The Pediatric infectious disease journal, 16(1), 1997, pp. 53-58
Authors:
SHINEFIELD HR
BLACK S
MOROZUMI P
FROEHLICH H
BERGEN R
LAVETTER A
KREMERS R
GLAUBER J
SOE G
ADELMAN T
ENSOR K
Citation: Hr. Shinefield et al., SAFETY AND IMMUNOGENICITY OF CONCOMITANT SEPARATE ADMINISTRATION OF MMR(II), TETRAMUNE (WYETH-LEDERLE DPT AND HBOC) AND VARIVAX (OKA MERCK VARICELLA VACCINE) VS CONCOMITANT INJECTIONS OF MMR(II) AND TETRAMUNE WITH VARIVAX GIVEN 6 WEEKS LATER/, Pediatric research, 39(4), 1996, pp. 660-660
Authors:
SHINEFIELD H
BLACK S
MOROZUMI P
FROEHLICH H
BERGEN R
LAVETTER A
KREMERS R
GLAUBER J
SOE G
ADELMAN T
ENSOR K
STAEHLE B
WHITE J
Citation: H. Shinefield et al., SAFETY AND IMMUNOGENICITY OF CONCOMITANT SEPARATE ADMINISTRATION OF MMRII VACCINE AND VARIVAX (OKA MERCK VARICELLA VACCINE) VS INJECTIONS OF MMRII AND VARIVAX GIVEN 6 WEEKS APART/, Pediatric research, 37(4), 1995, pp. 188-188
Citation: S. Nader et al., AGE-RELATED DIFFERENCES IN CELL-MEDIATED-IMMUNITY TO VARICELLA-ZOSTERVIRUS AMONG CHILDREN AND ADULTS IMMUNIZED WITH LIVE ATTENUATED VARICELLA VACCINE, The Journal of infectious diseases, 171(1), 1995, pp. 13-17